World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
79
Citations
23620
World Ranking
1680
National Ranking
828

Medicine

D-Index
81
Citations
24134
World Ranking
16651
National Ranking
8358

William E. Carson publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where William E. Carson sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 369 publications — 77th percentile

77% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

William E. Carson D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where William E. Carson sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 79 D-Index — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

William E. Carson is affiliated with The Ohio State University in the United States. Their research is predominantly situated within the field of Medicine, with a strong focus on Oncology and related subfields. The scientist's work spans Oncology, Immunology, Molecular Biology, Cancer Research, and Epidemiology, reflecting a multidisciplinary approach to medical research.

The main research topics covered in their publications include Cancer Immunotherapy and Biomarkers, Immune cells in cancer, Immune Cell Function and Interaction, Lung Cancer Research Studies, Neuroendocrine Tumor Research Advances, Immunotherapy and Immune Responses, and CAR-T cell therapy research.

Frequent publication venues for William E. Carson include Journal of Clinical Oncology and Cancer Research, each with 13 publications. Other notable venues are Annals of Surgical Oncology, Psycho-Neuroendocrinology, and bioRxiv (Cold Spring Harbor Laboratory).

William E. Carson has frequently collaborated with several co-authors, notably Brooke Benner, Himanshu Savardekar, Robert Wesolowski, Emily Schwarz, and Kari Kendra.

Selected recent papers authored or co-authored by William E. Carson include:

  • Pexidartinib, a Novel Small Molecule CSF-1R Inhibitor in Use for Tenosynovial Giant Cell Tumor: A Systematic Review of Pre-Clinical and Clinical Development (2020), published in Drug Design Development and Therapy
  • Biomimetic nanoparticles deliver mRNAs encoding costimulatory receptors and enhance T cell mediated cancer immunotherapy (2021), published in Nature Communications
  • CD200 promotes immunosuppression in the pancreatic tumor microenvironment (2020), published in Journal for ImmunoTherapy of Cancer
  • Depression and anxiety in colorectal cancer patients: Ties to pain, fatigue, and inflammation (2022), published in Psycho-Oncology
  • Phase 2 study of ibrutinib in classic and variant hairy cell leukemia (2021), published in Blood

Best Publications

  • Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset

    Megan A. Cooper;Todd A. Fehniger;Sarah C. Turner;Kenneth S. Chen

  • Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor.

    William E. Carson;Judith G. Giri;Matthew J. Lindemann;Michael L. Linett

  • Psychologic Intervention Improves Survival for Breast Cancer Patients: A Randomized Clinical Trial

    Barbara L. Andersen;Hae-Chung Yang;William B. Farrar;Deanna M. Golden-Kreutz

  • Psychological, Behavioral, and Immune Changes After a Psychological Intervention: A Clinical Trial

    Barbara L. Andersen;William B. Farrar;Deanna M. Golden-Kreutz;Ronald Glaser

  • A potential role for interleukin-15 in the regulation of human natural killer cell survival.

    W E Carson;T A Fehniger;S Haldar;K Eckhert

  • Cutaneous melanoma, version 2.2019

    Daniel G. Coit;John A. Thompson;Mark R. Albertini;Christopher Barker

  • Pain, depression, and fatigue: loneliness as a longitudinal risk factor.

    Lisa M. Jaremka;Rebecca R. Andridge;Christopher P. Fagundes;Catherine M. Alfano

  • Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro.

    William E. Carson;Mary E. Ross;Robert A. Baiocchi;Melanie J. Marien

  • Myeloid derived suppressor cells – a new therapeutic target in the treatment of cancer

    Robert Wesolowski;Joseph Markowitz;William E Carson

  • Melanoma, version 2.2016 clinical practice guidelines in oncology

    Daniel G. Coit;John A. Thompson;Alain Algazi;Robert Andtbacka

  • Flt3 Ligand Promotes the Generation of a Distinct CD34+Human Natural Killer Cell Progenitor That Responds to Interleukin-15

    Haixin Yu;Todd A. Fehniger;Todd A. Fehniger;Todd A. Fehniger;Pascal Fuchshuber;Pascal Fuchshuber;Pascal Fuchshuber;Karl S. Thiel;Karl S. Thiel;Karl S. Thiel

  • Distress reduction from a psychological intervention contributes to improved health for cancer patients

    Barbara L. Andersen;William B. Farrar;Deanna Golden-Kreutz;Charles F. Emery

  • Systemic Delivery of Anti-miRNA for Suppression of Triple Negative Breast Cancer Utilizing RNA Nanotechnology.

    Dan Shu;Hui Li;Yi Shu;Gaofeng Xiong

  • Social support predicts inflammation, pain, and depressive symptoms: Longitudinal relationships among breast cancer survivors

    Spenser Hughes;Lisa M. Jaremka;Catherine M. Alfano;Ronald Glaser

  • The functional characterization of interleukin-10 receptor expression on human natural killer cells.

    William E. Carson;Matthew J. Lindemann;Robert Baiocchi;Michael Linett

  • Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: Novel anti-tumor mechanisms of Cannabidiol in breast cancer

    Mohamad Elbaz;Mohd W. Nasser;Janani Ravi;Nissar A. Wani

  • Sentinel node biopsy in breast cancer.

    John M. Barnwell;Mark A. Arredondo;Daniel Kollmorgen;John F. Gibbs

  • Myeloid-Derived Suppressor Cell Inhibition of the IFN Response in Tumor-Bearing Mice

    Bethany L Mundy-Bosse;Gregory B. Lesinski;Alena C Jaime-Ramirez;Kristen Benninger

  • IL-12 enhances the natural killer cell cytokine response to Ab-coated tumor cells

    Robin Parihar;Julie Dierksheide;Yan Hu;William E. Carson

  • Nitric Oxide Production by Myeloid-Derived Suppressor Cells Plays a Role in Impairing Fc Receptor-Mediated Natural Killer Cell Function.

    Andrew Stiff;Prashant Trikha;Bethany L Mundy-Bosse;Elizabeth L McMichael

  • Signaling pathways involved in MDSC regulation.

    Prashant Trikha;William E. Carson

Frequent Co-Authors

Susheela Tridandapani
Susheela Tridandapani The Ohio State University
Michael A. Caligiuri
Michael A. Caligiuri City Of Hope National Medical Center
John C. Byrd
John C. Byrd University of Pittsburgh Cancer Institute
Janice K. Kiecolt-Glaser
Janice K. Kiecolt-Glaser The Ohio State University
Barbara L. Andersen
Barbara L. Andersen The Ohio State University
Charles L. Shapiro
Charles L. Shapiro Icahn School of Medicine at Mount Sinai
Albert de la Chapelle
Albert de la Chapelle The Ohio State University
Michael R. Grever
Michael R. Grever The Ohio State University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in branching out from Immunology into healthcare, various online nursing degrees offer accessible routes. For example, many non-nurses in Florida explore online rn programs for non nurses in florida, which allow individuals to start a nursing career without prior clinical experience.

If you’re looking to accelerate your nursing education, accelerated nursing programs near me provide intensive, fast-track options to earn your Bachelor of Science in Nursing (BSN) efficiently.

For those considering entry-level nursing roles, identifying the easy lpn programs to get into can be a strategic way to enter the field quickly, offering practical experience and a pathway to further study.

Advanced practice roles require more specialized education, but some candidates seek out which nurse practitioner program is easiest to balance their career advancement with personal commitments.

Exploring these related degrees can complement an Immunology background, broadening career prospects in healthcare and research sectors.

Best Scientists Citing William E. Carson

Trending Scientists

Recently Published Articles